CHA News Article

HRSA Selects Apexus to Continue as 340B Program Prime Vendor

The Health Resources and Services Administration has announced that it has selected Apexus to continue as the prime vendor for the 340B drug pricing program through Sept. 29, 2019. As the prime vendor, Apexus works with 340B program stakeholders to negotiate discounts on pharmaceuticals and offers tools and resources to help 340B participants comply with program requirements. For more information, visit